Skip to content

Effect of Nasal Spray Dexmedetomidine on Emergence Delirium Prevention in Total Hip Replacement

Effect of Nasal Spray Dexmedetomidine on Emergence Delirium Prevention in Total Hip Replacement in the Elderly Under General Anesthesia: a Randomized Clinical Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06579001
Enrollment
264
Registered
2024-08-30
Start date
2024-11-21
Completion date
2025-04-08
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Brief summary

Emergence Delirium (ED) is a common postoperative complication refers to an acute brain dysfunction that occurs during the recovery from general anesthesia, which is mainly characterized by sudden attention and consciousness disorders. The occurrence of ED increases the risk of self-injury, wound dehiscence, accidental catheter dislocation, and postoperative delirium, and is also associated with postoperative cognitive deterioration and increased utilization of medical resources after discharge.

Detailed description

The incidence of hip fracture after surgery in patients over 55 years old is about 45%, and ED is highly predictive of delirium during postoperative hospitalization, which occurs in about 1/3 of ED patients during postoperative hospitalization. It has been suggested that if delirium is monitored only on the first postoperative day and not at the PACU stage, up to 53% of delirium cases may be missed. Studies have shown that perioperative application of dexmedetomidine can reduce the risk of postoperative delirium to a certain extent. However, intravenous dexmedetomidine usually leads to problems with delayed extubation, residual sedation, and prolonged PACU stay. Previous studies have shown that intranasal dexmedetomidine improves perioperative sleep quality and neurocognitive deficits in elderly patients undergoing laparoscopic gynecologic surgery. Compared with intravenous administration, intranasal administration of dexmedetomidine resulted in milder hemodynamic fluctuations. However, stable nasal spray bioavailability is superior to intravenous dosage forms for nasal use. Based on the above background, this study aims to investigate the effect of nasal spray of dexmedetomidine on the prevention of emergence delirium after total hip replacement in elderly patients.

Interventions

DRUGNasal spray dexmedetomidine

Nasal spray dexmedetomidine or saline was used 100ug per patient acording to the group assignment

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥60 years old 2. Total hip arthroplasty under general anesthesia 3. ASA II-III 4. Informed consent was obtained from patients or their guardians

Exclusion criteria

1. Allergy or contraindication to dexmedetomidine 2. Severe rhinitis and nasal deformity 3. Severe bradycardia (heart rate \<50 beats/minute) or atrioventricular block of grade 2 or higher, permanent pacemaker implantation, severe heart failure or ejection fraction \<30% 4. Patients with previous myocardial infarction, unstable angina pectoris, severe arrhythmia, and cardiac insufficiency 5. Emergency surgery 6. Severe hepatic and renal dysfunction (Child-Pugh class B and C, CKD3-5) 7. Preoperative mental illness, cognitive impairment, and communication difficulties could not be evaluated in the study 8. Preoperative delirium was present

Design outcomes

Primary

MeasureTime frameDescription
emergency deliriumpostoperativeRASS&CAM-ICU, delirium was judged according to whether there were positive features in the questionnaire

Secondary

MeasureTime frameDescription
Postoperative deliriumpostoperative 3 days3D-CAM,delirium was judged according to whether there were positive features in the questionnaire
time to extubationpostoperative 3 daystime to extubation
PACU staypostoperative 3 dayslength of PACU stay
Preoperative anxiety scorepreoperativePerioperative anxiety scale,PAS-7, score range: 0-28, higher score means more anxiety
PONVpostoperative 3 daysthe incidence of nausea and /or vomiting
sleep qualitypostoperative 3 daysRCSQ, 0-100, higher score means higher sleep quality
Pain scorepostoperative 3 daysNRS, 0-10, 0 means no pain, 10 means severe pain
Hemodynamic changesintroperativebetween drug administration and anesthesia introduction

Countries

China

Contacts

Primary ContactMin Yan
zryanmin@zju.edu.cn0571-87783759

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026